2nd Quarter - Report

MGD STRATEGIES LLC for ESOPHAGEAL CANCER ACTION NETWORK (ECAN)

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Inclusion of esophageal cancer in the FY 2026 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2026 LHHS Appropriations bill Inclusion of esophageal cancer in the FY 2027 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2027 LHHS Appropriations bill

LobbyistCovered position, as disclosed
MEGAN GORDON DON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Support passage of the Clinical Trials Modernization Act (S. 4440/H.R. 3521) Support passage of the Gerald E. Connolly Esophageal Cancer Awareness Act (HR3490; Public Law No. 119-96)

LobbyistCovered position, as disclosed
MEGAN GORDON DON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3521 (119th), H.R. 3490 (119th), S. 4440 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.